CompletedPhase 3NCT00000714
An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved Therapies
Studying Pneumocystosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Feinberg J
- Intervention
- Trimetrexate glucuronate(drug)
- Eligibility
- 12 years · All sexes
- Timeline
- 2004
Study locations (21)
- Univ of Miami School of Medicine, Miami, Florida, United States
- Northwestern Univ Med School, Chicago, Illinois, United States
- Indiana Univ Hosp, Indianapolis, Indiana, United States
- Tulane Univ School of Medicine, New Orleans, Louisiana, United States
- Johns Hopkins Hosp, Baltimore, Maryland, United States
- Beth Israel Deaconess - West Campus, Boston, Massachusetts, United States
- Univ of Massachusetts Med Ctr, Worcester, Massachusetts, United States
- Warner-Lambert Parke-Davis, Morris Plains, New Jersey, United States
- SUNY / Erie County Med Ctr at Buffalo, Buffalo, New York, United States
- City Hosp Ctr at Elmhurst / Mount Sinai Hosp, Elmhurst, New York, United States
- Beth Israel Med Ctr, New York, New York, United States
- Bellevue Hosp / New York Univ Med Ctr, New York, New York, United States
- Mount Sinai Med Ctr, New York, New York, United States
- Univ of Rochester Medical Center, Rochester, New York, United States
- SUNY - Stony Brook, Stony Brook, New York, United States
- +6 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00000714 on ClinicalTrials.govOther trials for Pneumocystosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT04851015Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii PneumoniaTodd C. Lee MD MPH FIDSA
- RECRUITINGPHASE4NCT06499233Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic DiseaseTongji Hospital
- ACTIVE NOT RECRUITINGNCT06431958Droplet Digital PCR and PCR-free BIOSensors for the Detection of Resistance-associated SNPs in Pneumocystis JiroveciiUniversity Hospital, Brest
- RECRUITINGPHASE2NCT05835479Rezafungin for Treatment of Pneumocystis Pneumonia in HIV AdultsMundipharma Research Limited
- RECRUITINGNCT07269314Introduction of Polymerase Chain Reaction (PCR) in Microbiology and ParasitologyFondazione IRCCS Policlinico San Matteo di Pavia
- RECRUITINGNCT06691321Caspofungin for Pneumocystis Pneumonia in PLWHIV.Instituto Nacional de Enfermedades Respiratorias
- ENROLLING BY INVITATIONNANCT03856229Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDSCentro de Investigación en. Enfermedades Infecciosas, Mexico